dr. crew on updated data with margetuximab in her2 breast cancer
Published 4 years ago • 117 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:39
dr. crew on the aphinity trial results in her2 breast cancer
-
1:31
dr. pegram on margetuximab plus chemo in her2 breast cancer
-
1:00
dr. blackwell discusses margetuximab for her2 breast cancer
-
1:39
dr. rugo on the impact of margetuximab based on cd16a fc receptors in her2 breast cancer
-
4:05
sophia trial in r/r her2 mbc
-
1:28
dr. dawar on challenges with neratinib in metastatic her2 breast cancer
-
2:35
dr. rugo on the phase iii sophia trial in her2 breast cancer
-
2:43
margetuximab for the treatment of her2-positive breast cancer
-
1:54
dr. murthy on her2climb trial results in her2 breast cancer
-
1:24
dr. catenacci on study of margetuximab plus pembrolizumab in gastric:gej cancer
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
6:55
extended adjuvant therapy for her2 early breast cancer
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
2:27
margetuximab plus chemotherapy in her2 breast cancer
-
1:45
dr. pegram on a phase ii trial of mgah22 in breast cancer
-
2:05
dr. geyer discusses challenges in her2-positive metastatic breast cancer management